Genetic screening of ANXA11 revealed novel mutations linked to amyotrophic lateral sclerosis.

Neurobiology of Aging
Elisa TeyssouStéphanie Millecamps

Abstract

ANXA11 mutations have previously been discovered in amyotrophic lateral sclerosis (ALS) motor neuron disease. To confirm the contribution of ANXA11 mutations to ALS, a large exome data set obtained from 330 French patients, including 150 familial ALS index cases and 180 sporadic ALS cases, was analyzed, leading to the identification of 3 rare ANXA11 variants in 5 patients. The novel p.L254V variant was associated with early onset sporadic ALS. The novel p.D40Y mutation and the p.G38R variant concerned patients with predominant pyramidal tract involvement and cognitive decline. Neuropathologic findings in a p.G38R carrier associated the presence of ALS typical inclusions within the spinal cord, massive degeneration of the lateral tracts, and type A frontotemporal lobar degeneration. This mutant form of annexin A11 accumulated in various brain regions and in spinal cord motor neurons, although its stability was decreased in patients' lymphoblasts. Because most ANXA11 inclusions were not colocalized with transactive response DNA-binding protein 43 or p62 deposits, ANXA11 aggregation does not seem mandatory to trigger neurodegeneration with additional participants/partner proteins that could intervene.

References

Apr 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·Yoshiaki FurukawaThomas V O'Halloran
Jul 6, 2010·Nucleic Acids Research·Kai WangHakon Hakonarson
Dec 15, 2010·Neuron·Janel O JohnsonBryan J Traynor
Jun 7, 2011·Acta Neuropathologica·Ian R A MackenzieVirginia M Y Lee
Nov 10, 2013·Neurobiology of Disease·Anna WeichertAlbrecht M Clement
Dec 21, 2013·Acta Neuropathologica·Ian R A MackenzieManuela Neumann
Feb 11, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Jiasheng WangFrederick T Greenaway
Apr 2, 2014·Nature Neuroscience·Janel O JohnsonBryan J Traynor
Jun 18, 2014·Brain : a Journal of Neurology·Sylvie BannwarthVéronique Paquis-Flucklinger
Dec 4, 2014·Human Molecular Genetics·Peter I JoyceAbraham Acevedo-Arozena
Feb 24, 2015·Science·Elizabeth T CirulliDavid B Goldstein
Mar 25, 2015·Nature Neuroscience·Axel FreischmidtJochen H Weishaupt
Oct 31, 2015·Neurologic Clinics·Shahram SaberiJohn Ravits
Mar 8, 2016·Brain : a Journal of Neurology·David BrennerJochen H Weishaupt
Apr 16, 2016·Nature Communications·Kelly L WilliamsIan P Blair
Jul 28, 2016·Nature Genetics·Kevin P KennaJohn E Landers
May 5, 2017·Science Translational Medicine·Bradley N SmithChristopher E Shaw
Mar 24, 2018·Neuron·Aude NicolasJohn E Landers
Oct 30, 2018·Nucleic Acids Research·Philipp RentzschMartin Kircher
Dec 5, 2019·Proceedings of the National Academy of Sciences of the United States of America·Aline de Araújo BrasilElis Cristina Araujo Eleutherio

❮ Previous
Next ❯

Citations

Mar 31, 2021·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Piero Andrea TemussiAnnalisa Pastore
Jun 9, 2021·Acta Neuropathologica Communications·Makoto SainouchiAkiyoshi Kakita

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.